Free Trial
ASX:ANR

Anatara Lifesciences (ANR) Stock Price, News & Analysis

Anatara Lifesciences logo

About Anatara Lifesciences Stock (ASX:ANR)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
3,950 shs
Average Volume
N/A
Market Capitalization
A$11.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ANR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Anatara Lifesciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ANR Stock News Headlines

October 16 Changes the Microchip Game — and Investing
While everyone's chasing the same AI plays, George Gilder is focused on something completely different. He says a 4-nanometer device that's 80 MILLION times more powerful than the chip he gave Reagan is now being made in America for the first time. And he's identified 3 companies that control this technology.tc pixel
See More Headlines

ANR Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Anatara Lifesciences investors own include Woodside Petroleum (WPL), Temple & Webster Group (TPW), Brompton Oil Split (OSP), Eagle Materials (EXP), BHP Group (BHP) and Ameriprise Financial (AMP).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:ANR
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$1.45 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-110.25%
Return on Assets
-59.01%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.49
Quick Ratio
4.69

Sales & Book Value

Annual Sales
A$1.25 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
2.33
Book Value
A$0.01 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
192,890,000
Free Float
N/A
Market Cap
A$11.74 million
Optionable
Not Optionable
Beta
0.72
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (ASX:ANR) was last updated on 10/19/2025 by MarketBeat.com Staff
From Our Partners